| Brivaracetam Impurity 28 | 2432911-32-3 | C15H27N3O3 |
| Brivaracetam Impurity 29 | 2179080-15-8 | C7H13NO |
| Brivaracetam Impurity 30 | 90719-32-7 | C10H11NO2 |
| Brivaracetam Impurity 31 | 2096999-79-8 | C7H14O3 |
| Brivaracetam Impurity 33 | 2101641-90-9 | C7H13ClO2 |
| Brivaracetam Impurity 36 | 2252417-17-5 | C11H22N2O3 |
| Brivaracetam Impurity 41 | 357338-13-7 | C11H18N2O2 |
| Brivaracetam Impurity 45 | 748760-80-7 | C13H26N2O3 |
| Brivaracetam Impurity 46 | 2242963-07-9 | C17H20N2O3 |
| Brivaracetam Impurity 47 | Not available | C11H19NO3 |
| Brivaracetam Impurity 63 | 930123-37-8 | C7H13NO |
| Brivaracetam Impurity 65 | 40651-89-6 | C4H8N2 |
| Brivaracetam Impurity 65 | 134807-43-5 | C11H20O4 |
| Brivaracetam Impurity 72 | 772292-30-5 | C9H18N2O3 |
| Brivaracetam Impurity 73 | 10547-88-3 | C7H12O2 |
| Brivaracetam Impurity 78 | 1956436-60-4 | C9H18O3 |
| Brivaracetam Impurity 79 | 2167633-39-6 | C9H18O3 |
| Brivaracetam Impurity 80 | 16496-51-8 | C6H10O2 |
| Brivaracetam Impurity 81 | 2200297-71-6 | C11H21BrO2 |
| Brivaracetam Impurity 89 | 22530-99-0 | C8H14O2 |
| Brivaracetam Impurity 99 | 81381-87-5 | C7H14O3 |
| Brivaracetam Impurity 101 | 2101641-91-0 | C7H13IO2 |
| Brivaracetam Impurity 104 | 16750-40-6 | C4H8N2 |
| Brivaracetam Impurity 106 | 112459-79-7 | C14H17NO3 |
| Brivaracetam Impurity 114 | 53657-15-1 | C7H12O2 |
| Brivaracetam Impurity 126 | 2052297-73-9 | C10H16O4 |
| Brivaracetam Impurity 127 | 930123-38-9 | C7H13NO |
| Brivaracetam impurity 130 | 3975-88-0 | C7H12O4 |
| Brivaracetam impurity 132 | 102-13-6 | C12H16O2 |
| Brivaracetam impurity 133 | 42918-86-5 | C12H15NO4 |
| Brivaracetam Impurity 135 | Not available | C8H14O2 |
| Brivaracetam Impurity 136 | 2755924-55-9 | C11H19NO3 |
| Brivaracetam Impurity 140 | 357334-83-9 | C11H20N2O2 |
| Brivudine | 69304-47-8 | C11H13BrN2O5 |
| Brivudine 5''-Monophosphate | 80860-82-8 | C11H14BrN2O8P |
| Brivudine 5'-Triphosphate | 77222-61-8 | C11H16BrN2O14P3 |
| Brivudine Impurity 1 | 74131-08-1 | C11H13ClN2O5 |
| Brivudine Impurity 2 | 78731-55-2 | C11H13BrN2O5 |
| Brivudine Impurity 3 | 40049-80-7 | C4H5Br3 |
| Brivudine Impurity 3 | 54-42-2 | C9H11IN2O5 |
| Brivudine Impurity 4 | 951-78-0 | C9H12N2O5 |
| Brivudine Impurity 4 | 21890-35-7 | C4H5Br |
| Brivudine Impurity 5 | 59-14-3 | C9H11BrN2O5 |
| Brivudine Impurity 5 | 56318-77-5 | C4H5Br |
| Brivudine Impurity 7 | 866836-88-6 | C11H12Br2N2O5 |
| Brivudine Impurity 8 | 34846-90-7 | C5H8O3 |
| Brivudine Impurity 9 | 69304-48-9 | C11H13IN2O5 |
| Brivudine Impurity 10 | 55520-67-7 | C11H14N2O5 |
| Brivudine Impurity 11 | 1053650-23-9 | C25H20Br2Cl2N2O7 |
| Brivudine Impurity 14 | 144301-84-8 | C6H12O4 |
| Brivudine Impurity 15 | 2640030-37-9 | C5H10O4 |
| Brivudine Impurity 18 | 144301-85-9 | C6H12O4 |
| Brivudine Impurity 19 | 113890-38-3 | C5H10O4 |
| Brivudine Impurity 20 | 114192-44-8 | C16H18N2O9 |
| Brivudine Impurity 21 | 61135-36-2 | C11H12Br2N2O5 |
| Brivudine Impurity 22 | 18546-37-7 | C5H10O4 |
| Brivudine Impurity 29 | 25137-84-2 | C25H22Cl2N2O7 |
| Brobactam Sodium Salt | 73335-78-1 | C8H9BrNNaO3S |
| Brolamine Hydrochloride 2 | 89878-72-8 | C18H27ClO2 |
| Brolamine Hydrochloride 7 | 89878-75-1 | C18H27ClO2 |
| Bromazepam EP Impurity A | 1563-56-0 | C12H9BrN2O |
| Bromazepam EP Impurity B | 41526-21-0 | C14H10BrClN2O2 |
| Bromazepam EP Impurity C | 868350-97-4 | C15H12BrN3O |
| Bromazepam EP Impurity D | 77616-97-8 | C14H10BrN3O |
| Bromazepam EP Impurity E | 1694-64-0 | C14H10Br2N2O2 |
| Bromazepam Imp. A (EP): (2-Amino-5-bromophenyl)- (pyridin-2-yl)methanone | 1563-56-0 | C12H9BrN2O |
| Bromazepam Imp. B (EP): N-[4-Bromo-2-(pyridin-2- ylcarbonyl)phenyl]-2-chloroacetamide | 41526-21-0 | C14H10BrClN2O2 |
| Bromazepam Imp. C (EP): 7-Bromo-5-(6-methylpyridin-2- yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 868350-97-4 | C15H12BrN3O |
| Bromazepam Imp. D (EP): 3-Amino-6-bromo-4-(pyridin- 2-yl)quinolin-2(1H)-one | 77616-97-8 | C14H10BrN3O |
| Bromazepam Imp. E (EP): 2-Bromo-N-[4-bromo-2-(pyridin- 2-ylcarbonyl)phenyl]acetamide | 1694-64-0 | C14H10Br2N2O2 |
| Bromfenac | 91714-93-1 | C15H11BrNNaO3 |
| Bromfenac Ethyl Ester | 102414-22-2 | C17H16BrNO3 |
| Bromfenac Impurity 2 | 91713-91-6 | C15H10BrNO2 |
| Bromfenac Impurity 3 | 241825-88-7 | C15H8BrNO3 |
| Bromfenac Impurity 3 | 1644279-16-2 | C30H18Br2N2O3 |
| Bromfenac Impurity 4 | 241496-82-2 | C14H10BrNO3 |
| Bromfenac impurity 7 | 126849-31-8 | C15H10NNaO4 |
| Bromfenac impurity 9 | 845276-75-7 | C13H10BrNO |
| Bromfenac impurity 12 | 61941-62-6 | C15H11ClNNaO3 |
| Bromfenac Isopropyl Ester | Not available | C18H18BrNO3 |
| Bromfenac Methyl Ester | Not available | C16H14BrNO3 |
| Bromfenac Related substance III | 1391052-54-2 | C15H9BrNNaO4 |
| Bromfenac sodium 1.5 Hydrate | 120638-55-3 | C30H28Br2N2Na2O9 |
| Bromfenac sodium Impurity C | 241825-87-6 | C15H10BrNO4 |
| Bromhexine | 3572-43-8 | C14H20Br2N2 |
| Bromhexine EP Impurity A | Not available | C7H7Br2NO |
| Bromhexine EP Impurity B | Not available | C7H5Br2NO |
| Bromhexine EP Impurity C | 57365-08-9 | C14H22N2 |
| Bromhexine EP Impurity D | 132004-28-5 | C14H21BrN2 |
| Bromhexine for system suitability | 611-75-6 | C14H21Br2ClN2 |
| Bromhexine hydrochloride EP impurity E | 1661064-00-1 | C15H21Br2N2+ |
| Bromhexine Hydrochloride Imp. A (EP): (2-Amino-3,5- dibromophenyl)methanol | 50739-76-9 | C7H7Br2NO |
| Bromhexine Hydrochloride Imp. B (EP): 2-Amino-3,5- dibromobenzaldehyde | 50910-55-9 | C7H5Br2NO |
| Bromhexine Hydrochloride Imp. C (EP): N-(2-Aminobenzyl)-N- methylcyclohexanamine | 57365-08-9 | C14H22N2 |
| Bromhexine Hydrochloride Imp. D (EP) as Dihydrochloride: N-(2- Amino-5-bromobenzyl)-N-methyl- cyclohexanamine Dihydrochloride | 10076-98-9 | C14H23BrCl2N2 |
| Bromhexine Hydrochloride Imp. E (EP) as Chloride: (3RS)-6,8- Dibromo-3-cyclohexyl-3-methyl-1,2,3,4- tetrahydroquinazolin-3-ium Chloride | 1660957-93-6 | C15H21Br2ClN2 |
| Bromhexine Hydrochloride Impurity I | 1631131-52-6 | C14H20BrClN2 |
| Bromhexine Impurity 6 | 100-60-7 | C7H15N |
| Bromhexine Impurity 8 | 21237-84-3 | C14H16Br2N2O |
| Bromhexine Impurity 8 | 18683-89-1 | C14H20Br2N2O |
| Bromhexine Impurity 9 | 80638-08-0 | C14H20N2O2 |
| Bromhexine Impurity 12 | 63471-27-2 | C14H21BrN2 |
| Bromhexine Impurity 17 | 606-00-8 | C8H7Br2NO2 |
| Bromhexine Impurity 18 | 2155876-24-5 | C8H5BrClNO2 |
| Bromhexine Impurity 24 | 100669-82-7 | C7H6Br2ClN |
| Bromhexine Impurity 25 | 100669-81-6 | C7H6Br3N |
| Bromhexine Impurity 26 | 2724689-57-8 | C14H20Br2N2O |
| Bromhexine impurity C | Not available | C14H22N2 |
| Bromhexine Impurity D | 10076-98-9 | C14H23BrCl2N2 |
| Bromhexine Impurity E | 1660957-93-6 | C15H21Br2ClN2 |
| Bromhexine Impurity G | 32193-43-4 | C14H20BrClN2 |
| Bromhexine Levulinamide Hydrochloride | Not available | C19H27Br2ClN2O2 |
| Bromhexine Levulinamide Hydrochloride (N-[2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]phenyl]-4-oxo-pentanamide Hydrochloride) | Not available | C19H27Br2ClN2O2 |
| Bromhexine N-Oxide | Not available | C14H20Br2N2O |
| Bromhexine N-Oxide | 2724689-57-8 | C14H20Br2N2O |
| Bromhexine Related Compound 3 | 2512203-87-9 | C14H16Br2N2O |
| Bromhexine-d3 HCl | Not available | C14H21Br2ClN2 |
| Bromoacetaldehyde dimethyl acetal | 7252-83-7 | C4H9BrO2 |
| Bromobenzene | 108-86-1 | C6H5Br |
| Bromocriptine | 25614-03-3 | C32H40BrN5O5 |
| Bromocriptine EP Impurity A | Not available | C32H38BrN5O4 |
| Bromocriptine EP Impurity D | 478-83-1 | C16H15BrN2O2 |
| Bromocriptine EP Impurity E | 2492-53-7 | C16H16BrN3O |
| Bromocriptine EP Impurity F | 82773-21-5 | C32H40BrN5O5 |
| Bromocriptine EP Impurity G | Not available | C33H42BrN5O5 |
| Bromocriptine Impurity 1 | 68944-88-7 | C32H40ClN5O5 |
| Bromocriptine impurity B | Not available | C32H41N5O5 |
| Bromocriptine mesilate for system suitability | 22260-51-1 | C33H44BrN5O8S |
| Bromocyanamide metabolites | 1414864-34-8 | C19H12BrClN6O |
| Bromododecane | 143-15-7 | C12H25Br |
| Bromophenolic acid impurity 4 | 2445168-29-4 | C16H14BrNO3 |
| Bromopride | 4093-35-0 | C14H22BrN3O2 |
| Bromopride HCl | 52423-56-0 | C14H23BrClN3O2 |
| Bromopride Impurity 1 | 67903-51-9 | C12H18BrN3O2 |
| Bromopride Impurity A | 94135-22-5 | C16H24BrN3O3 |
| Bromopride Impurity B | 4093-34-9 | C11H12BrNO4 |
| Bromopride Impurity C | 35290-97-2 | C8H8BrNO3 |
| Bromperidol EP Impurity B | Not available | C21H23BrFNO2 |
| Bromperidol EP Impurity C | 1347289-37-5 | C27H28FNO2 |
| Bromperidol EP Impurity D | Not available | C23H27BrFNO2 |
| Bromperidol EP Impurity E | Not available | C32H36Br2N2O3 |
| Bromperidol EP Impurity F | Not available | C27H27BrFNO2 |
| Bromperidoli decanoas | 75067-66-2 | C31H41BrFNO3 |
| Brompheniramine EP Impurity A | 132-22-9 | C16H19ClN2 |
| Brompheniramine Impurity 1 | 18453-10-6 | C19H21BrN2O4 |
| Brompheniramine Impurity 2 | 65676-22-4 | C17H18BrN3 |
| Brompheniramine Impurity 3 | 85750-24-9 | C13H9BrN2 |
| Brompheniramine Maleate Imp. A (EP) as Maleate: Chlorphenamine Maleate | 113-92-8 | C20H23ClN2O4 |
| Brompheniramine Maleate Imp. B (EP) as Maleate: Dexchlorpheniramine Maleate | 2438-32-6 | C20H23ClN2O4 |
| Brompheniramine Maleate Imp. C (EP) as Maleate: (3RS)-N,N-Dimethyl- 3-phenyl-3-(pyridin-2-yl)propan-1-amine Maleate (Pheniramine Maleate) | 132-20-7 | C20H24N2O4 |
| Brompheniramine Maleate Imp. C (EP): (3RS)-N,N-Dimethyl-3-phenyl- 3-(pyridin-2-yl)propan-1-amine (Pheniramine) | 86-21-5 | C16H20N2 |
| Brompheniramine N-Oxide | 18453-29-7 | C16H19BrN2O |
| Brompheniramine N-Oxide Dihydrochloride | Not available | C16H21BrCl2N2O |
| Brompheniramine N-Oxide Maleate | Not available | C20H23BrN2O5 |
| Brotizolam impurity B | 57801-97-5 | C14H8BrClN4S |
| Brovudine cis isomer impurity 14 | 77530-02-0 | C11H13BrN2O5 |
| Bucladesine Impurity 1 | 55443-13-5 | C14H17N5NaO7P |
| Bucladesine Impurity 5 | 1053-73-2 | C10H15N5O10P2 |
| Bucladesine sodium | 16980-89-5 | C18H23N5NaO8P |
| Budesonide EP Impurity A | 13951-70-7 | C21H28O6 |
| Budesonide EP Impurity B | 1040085-98-0 | C23H30O6 |
| Budesonide EP Impurity C | 1040085-99-1 | C25H34O6 |
| Budesonide EP Impurity F | 638-94-8 | C24H32O6 |
| Budesonide Imp. A (EP): 11 ,16 ,17,21-Tetrahydroxy- pregna-1,4-diene-3,20-dione (16 -Hydroxy- prednisolone) | 13951-70-7 | C21H28O6 |
| Budesonide Imp. B (EP): 16 ,17-[(1RS)-Ethylidenebis(oxy)]- 11 ,21-dihydroxypregna-1,4-diene-3,20-dione | 1040085-98-0 | C23H30O6 |
| Budesonide Imp. F (EP): 16 ,17-[1-Methylethylidenebis(oxy)]-11 ,21- dihydroxypregna-1,4-diene-3,20-dione (Desonide) | 638-94-8 | C24H32O6 |
| Budesonide Imp. G (EP): 16 ,17-[(1RS)-Butylidenebis(oxy)]- 11 ,21-dihydroxypregn-4-ene-3,20-dione (1,2-Dihydrobudesonide) | 137174-25-5 | C25H36O6 |
| Budesonide Imp. H (EP): 16 ,17-[(1RS)-Butylidenebis(oxy)]- 21-hydroxypregna-1,4,9(11)-triene-3,20-dione | 313474-58-7 | C25H32O5 |
| Budesonide Imp. I (EP): 11 ,17,21-Trihydroxy-3,20-dioxopregna- 1,4-dien-16 -yl Butanoate | 113930-13-5 | C25H34O7 |
| Budesonide Imp. J (EP): 16 ,17-[(1RS)-Butylidenebis(oxy)]-9 - bromo-11 ,21-dihydroxypregna-1,4-diene-3,20-dione | 313474-59-8 | C25H33BrO6 |
| Budesonide Impurity 5 | 4380-55-6 | C23H28O5 |
| Budesonide Impurity 6 | 37413-91-5 | C23H26O4 |
| Budesonide impurity 17 | 77017-17-5 | C21H26O5 |
| Budesonide impurity 18 | Not available | C21H26O5 |
| Budesonide Impurity 20 | 2408495-96-3 | C29H40O7 |
| Budesonide impurity 21 | 638-93-7 | C24H34O6 |
| Budesonide Impurity 22 | 3044-42-6 | C23H28O5 |
| Budesonide impurity 23 | 3754-07-2 | C26H32O7 |
| Budesonide Impurity 23 | 3103-17-1 | C21H26O4 |
| Budesonide impurity 24 | 131918-67-7 | C24H30O6 |
| Budesonide impurity 25 | 117782-94-2 | C23H30O6 |
| Budesonide Impurity 25 | 131918-73-5 | C21H26O6 |
| Budesonide impurity 26 | 57171-18-3 | C24H30O6 |
| Budesonide Impurity 27 | 39672-76-9 | C21H26O5 |
| Budesonide impurity 27 | 25092-32-4 | C26H32O7 |
| Budesonide Impurity 33 (Triethylamine Salt) | 1436872-65-9 | C31H49NO9S |
| Budesonide Impurity 34 | 3949-79-9 | C23H28O7 |
| Budesonide Impurity 36 | 25092-25-5 | C26H34O7 |
| Budesonide impurity standard | 51333-22-3 | C25H34O6 |
| Budesonide Related Compound E | 131918-64-4 | C25H32O6 |
| Budesonide Related Compound G | 137174-25-5 | C25H36O6 |
| Budesonide Related Compound L | 216453-74-6 | C25H32O6 |
| Bufexamac Imp. A (EP): 2-(4-Butoxyphenyl)acetic Acid | 4547-57-3 | C12H16O3 |
| Bufexamac Imp. B (EP): Methyl 2-(4-Butoxyphenyl)- acetate | 29056-06-2 | C13H18O3 |
| Bufexamac Imp. C (EP): Butyl 2-(4-Butoxyphenyl)- acetate | 1185726-73-1 | C16H24O3 |
| Bufexamac Imp. D (EP): 2-(4-Butoxyphenyl)acetamide | 3413-59-0 | C12H17NO2 |
| Bufexamac impurity A | 4547-57-3 | C12H16O3 |
| Bufexamac impurity B | 29056-06-2 | C13H18O3 |
| Bufexamac impurity C | 1185726-73-1 | C16H24O3 |
| Bufexamac impurity D | 3413-59-0 | C12H17NO2 |
| Buflomedil for peak identification | 35543-24-9 | C17H26ClNO4 |
| Buflomedil Hydrochloride Imp. A (EP) as Hydrochloride: 4-(Pyrrolidin- 1-yl)-1-(2-hydroxy-4,6-dimethoxyphenyl)- butan-1-one Hydrochloride (o-Desmethyl-Buflomedil Hydrochloride) | 70585-57-8 | C16H24ClNO4 |
| Buflomedil Hydrochloride Imp. B (EP) as Hydrochloride: 4-(Pyrrolidin- 1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)- butan-1-one Hydrochloride (p-Desmethyl-Buflomedil Hydrochloride) | 70585-59-0 | C16H24ClNO4 |
| Buflomedil impurity B | 79967-07-0 | C16H23NO4 |
| Buflomedil N-Oxide Hydrochloride | Not available | C17H26ClNO5 |
| Buflomedil N-Oxide Hydrochloride | 2731671-51-3 | C17H26ClNO5 |
| Bufuralol | 54340-62-4 | C16H23NO2 |
| Bufuralol HCl | 60398-91-6 | C16H24ClNO2 |
| Bufuralol Impurity 1 | 57704-16-2 | C16H23NO3 |
| Bumetanide EP Impurity A | 28328-53-2 | C13H10N2O7S |
| Bumetanide EP Impurity B | 28328-54-3 | C13H12N2O5S |
| Bumetanide EP Impurity C | 32643-00-8 | C21H28N2O5S |
| Bumetanide EP Impurity D | 153012-65-8 | C21H28N2O5S |
| Bumetanide Imp. A (EP): 3-Nitro-4-phenoxy-5-sulphamoylbenzoic Acid | 28328-53-2 | C13H10N2O7S |
| Bumetanide Imp. B (EP): 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid | 28328-54-3 | C13H12N2O5S |
| Bumetanide Impurity 2 | 1236290-34-8 | C21H28N2O5S |
| Bumetanide Impurity 5 | 28328-56-5 | C14H14N2O5S |
| Bumetanide Impurity 8 | 32642-56-1 | C7H6N2O7S |
| Bumetanide Impurity 10 | 22892-96-2 | C7H5ClN2O6S |
| Bumetanide Impurity 12 | 22892-95-1 | C7H3Cl2NO6S |
| Bumetanide Impurity 13 | 130262-91-8 | C7H4ClNO7S |
| Bumetanide Impurity 14 | 69236-82-4 | C7H7ClN2O2 |
| Bumetanide Impurity 15 | 84211-27-8 | C7H7NO4 |
| Bumetanide Impurity 17 | 860694-39-9 | C7H8N2O4S |
| Bumetanide Impurity 17 | 28469-01-4 | C21H28N2O5S |
| Bumetanide Impurity 23 | 25317-76-4 | C7H7ClN2O4S |
| Bumetanide Impurity 29 | 688047-82-7 | C17H17NO3 |
| Bumetanide Impurity 31 | 22893-29-4 | C11H15ClN2O4S |
| Bumetanide Impurity 41 | 62971-57-7 | C7H5Cl2NO4S |
| Bumetanide Impurity 43 | 202209-14-1 | C13H9NO5 |
| Bumetanide Impurity 43 | 26388-47-6 | C26H28O13 |
| Bumetanide Impurity 47 | 1290117-25-7 | C7H4ClNO5 |
| Bumetanide Impurity 48 | 94610-14-7 | C17H20N2O6S |
| Bumetanide Impurity 50 | 37531-34-3 | C13H11NO5S |
| Bumetanide Impurity 50 | 688047-81-6 | C17H19NO5S |
| Bumetanide impurity A | 28328-53-2 | C13H10N2O7S |
| Bumetanide impurity B | 28328-54-3 | C13H12N2O5S |
| Bumetanide Photodegradable Impurity 16 | 105641-65-4 | C17H19NO3 |
| Bumetanide Related Compound A | 28328-54-3 | C13H12N2O5S |
| Bumetanide Related Compound B | 28328-53-2 | C13H10N2O7S |
| Bumetanide β-D-Glucuronide | 102623-14-3 | C23H28N2O11S |
| Bumetrizole methyl-d3 | Not available | C17H18ClN3O |
| Bupivacaine EP Impurity A | 39627-98-0 | C14H14N2O |
| Bupivacaine EP Impurity B | 15883-20-2 | C14H20N2O |
| Bupivacaine EP Impurity C | 1797894-80-4 | C14H17NO |
| Bupivacaine EP Impurity D | 1037184-07-8 | C14H19Cl2NO |
| Bupivacaine EP Impurity E | 1330172-81-0 | C18H30N2O |
| Bupivacaine HCl | 18010-40-7 | C18H29ClN2O |
| Bupivacaine Hydrochloride | 14252-80-3 | C18H29ClN2O |
| Bupivacaine Hydrochloride Imp. A (EP): N-(2,6-Dimethylphenyl)pyridine- 2-carboxamide | 39627-98-0 | C14H14N2O |
